| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 27.054 | 0 | 0 | - | 0 | 1.757 | 0 | 937 | 46.560 | 142.277 |
| Total Income - EUR | 27.093 | 0 | 0 | - | 0 | 1.757 | 1 | 1.003 | 46.581 | 158.360 |
| Total Expenses - EUR | 28.521 | 2.942 | 2.620 | - | 0 | 264 | 2.918 | 5.949 | 51.110 | 148.187 |
| Gross Profit/Loss - EUR | -1.428 | -2.942 | -2.620 | - | 0 | 1.494 | -2.917 | -4.946 | -4.529 | 10.173 |
| Net Profit/Loss - EUR | -1.428 | -2.942 | -2.620 | - | 0 | 1.476 | -2.917 | -4.974 | -5.306 | 7.695 |
| Employees | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Ideal Vita Pharma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 2.737 | 20.124 |
| Current Assets | 1.350 | 719 | 707 | - | 680 | 57 | 11.663 | 8.260 | 22.575 | 41.175 |
| Inventories | 248 | 246 | 242 | - | 233 | 0 | 7.448 | 7.294 | 10.889 | 5.558 |
| Receivables | 58 | 57 | 56 | - | 54 | 0 | 1.353 | 903 | 5.949 | 7.734 |
| Cash | 1.044 | 416 | 409 | - | 394 | 57 | 2.861 | 63 | 5.738 | 27.884 |
| Shareholders Funds | -3.945 | -6.847 | -9.351 | - | -9.001 | -7.313 | -10.069 | -10.829 | -16.102 | -8.328 |
| Social Capital | 45 | 45 | 44 | - | 42 | 83 | 81 | 81 | 81 | 80 |
| Debts | 5.295 | 7.566 | 10.057 | - | 9.682 | 7.370 | 21.731 | 19.108 | 41.458 | 69.673 |
| Income in Advance | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4520
|
|||||||||
Comments - Ideal Vita Pharma S.r.l.